ASML is securing commitments from top chipmakers including Samsung and TSMC to use its high-end lithography machines, which will allow greater chip production and lower costs as they race to meet AI demand.
Novartis has suffered its third disappointing drug trial result in a week, and the stock's decline is likely to continue after another late-stage trial miss.